New autoantigens in rheumatoid arthritis (ra): Screening 8268 protein arrays with sera from patients with ra

Annals of the Rheumatic Diseases

Volumn 68, Issue 4, 2009, Pages 591-594

  Auger, I ^a,b   Balandraud, N ^a   Rak, J ^a   Lambert, N ^a   Martin, M ^a   Roudier, J ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIGEN; B RAF KINASE; HLA DR ANTIGEN; IMMUNOGLOBULIN G; PEPTIDYL ARGININE DEIMINASE 4; PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE TYPE II GAMMA; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA1; UNCLASSIFIED DRUG; AUTOANTIBODY; BRAF PROTEIN, HUMAN; HYDROLASE; PEPTIDYLARGININE DEIMINASE TYPE IV; PROTEIN KINASE C;

ARTICLE; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMAN; LUPUS VULGARIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; RHEUMATOID ARTHRITIS; SCREENING; SERUM; SPONDYLOARTHROPATHY; SYSTEMIC SCLEROSIS; WESTERN BLOTTING; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; METHODOLOGY;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYDROLASES; IMMUNOGLOBULIN G; PROTEIN ARRAY ANALYSIS; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS B-RAF;

EID: 65249190753     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.096917     Document Type: Article

References (15)

1. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
2. Reviron D, Perdriger A, Toussirot E, Wendling D, Balandraud N, Guis S, et al. Influence of shared epitope negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis. Arthritis Rheum 2001;44:535-40.
3. Auger I, Sebbag M, Vincent C, Balandraud N, Guis S, Nogueira L, et al. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen. Arthritis Rheum 2005;52:3424-32.
4. Auger I, Roudier C, Guis S, Balandraud N, Roudier J. HLA-DR B10404 is strongly associated with anti-calpastatin antibodies in rheumatoid arthritis Ann Rheum Dis 2007;66:1588-93.
5. Michaud GA, Mattoon D, Schweitzer B, Predki PF. Biomarker identification using Protoarray high density protein microarrays: profiling autoantibodies in disease. Carlsbad, California, USA: Invitrogen, 2008.
6. Hudson ME, Pozdnyakova I, Haines K, Mor G, Snyder M. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci USA 2007;44:17494-9.
7. Andersen MH, Fensterle J, Ugurel S, Reker S, Houben R, Guldberg P, et al. Immunogenicity of constitutively active V599E Braf. Cancer Res 2004;64:5456-60.
8. Fensterle J, Becker JC, Potapenko T, Heimbach V, Vetter CS, Bröcker EB, et al. B-Raf specific antibody responses in melanoma patients. BMC Cancer 2004;12:4:62-70.
9. Roberts TM. Cell biology: a signal chain of events. Nature 1992;360:534-5.
10. Crews CM, Erikson RL. Extracellular signals and reversible protein phosphorylation: what to Mek of it all. Cell 1993;74:215-17.
11. Thalhamer T, McGrath MA, Harnett MM. MAPKs and their relevance to arthritis and inflammation. Rheumatology 2008;47:409-14.
12. Takizawa Y, Sawada T, Suzuki A, Yamada R, Inoue T, Yamamoto K. Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis. Scand J Rheumatol 2005;3:212-15.
13. Roth EB, Stenberg P, Book C, Sjöberg K. Antibodies against transglutaminases, peptidylarginine deiminase and citrulline in rheumatoid arthritis: new pathways to epitope spreading. Clin Exp Rheumatol 2006;1:12-18.
14. Halvorsen EH, Pollmann S, Gilboe IM, van der Heijde D, Landewé R, Odegard S, et al. Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity. Ann Rheum Dis 2008;67:414-17.
15. Zhao J, Zhao Y, He J, Jia R, Li Z. Prevalence and significance of antipeptidylarginine deiminase 4 antibodies in rheumatoid arthritis. J Rheumatol 2008;35:969-74.